帕拉米韦中间体2

帕拉米韦中间体2性质、用途与生产工艺

帕拉米韦中间体2 上下游产品信息

上游原料

下游产品

帕拉米韦中间体2 生产厂家

229613-93-8, 帕拉米韦中间体2 相关搜索:

• 229613-93-8
• 其他中间体材料
• 189-帕拉米韦
• 帕拉米韦
• 杂质对照品
• 药用中间体
• 医药化工原料
• 杂质对照品
• 对照品-杂质对照品
• 医药原料
• 医药中间体
• C18H30N2O5
• (3AR,4R,6S,6AS)-4-[叔丁氧羰基氨基]-3-(1-乙基丙基)-3A,5,6,6A-四氢-4H-环戊并[D]异噁唑-6-羧酸甲酯
• (3AR,4R,6S,6AS)-4-[叔丁氧羰基氨基]-3-(1-乙基丙基)-3A,5,6,6A-四氢-4H-环戊并[D]异恶唑-6-羧酸甲酯(帕拉米韦中间体2)
• 帕拉米韦杂质07
• (3AR,4R,6S,6AS)-甲基4-((叔丁氧羰基)氨基)-3-(戊基-3-基)-4,5,6,6A-四氢-3AH-环戊[D]异噁唑-6-羧酸盐
• 帕拉米韦杂质PERAMIVIR IMPURITY 1
• (3AR,4R,6S,6AS)-4-[[(1,1-二甲基乙氧基)羰基]氨基]-3-(1'-乙基丙基)-3A,5,6,6A-四氢-4H-环戊烷并[D]异噁唑-6-羧酸甲酯
• (3AS,4S,6R,6AR)-4-[叔丁氧羰基氨基]-3-(1-乙基丙基)-3A,5,6,6A-四氢-4H-环戊并[D]异恶唑-6-羧酸甲酯
• 帕拉米韦中间体对映异构体
• 帕拉米韦中间体,(3AR,4R,6S,6AS)-4-[[(1,1-二甲基乙氧基)羰基]氨基]-3-(1'-乙基丙基)-3A,5,6,6A-四氢-4H-环戊烷并[D]异噁唑-6-羧酸甲酯
• 帕拉米韦杂质14
• 帕拉米韦杂质
• 帕拉米韦中间体2
• (3AR,4R,6S,6AS)-4-[叔丁氧羰基氨基]-3-(1-乙基丙基)-3A,5,6,6A-四氢-4H-环戊并[D]异恶唑-6-羧酸甲酯
• 帕拉米韦中间体2 1KG
• 229613-93-8
• (3R.AR.6S6aS)-Methry1 4-tetebutotocroo--(an-an-3-45.6.a.tatrahcyro-3aHarcloentatdjisoxazol-caoxyatea
• methyl (3aR,4R,6S,6aS)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate
• Peramivir intermediate M8
• Peramivir impurities 7
• methyl (3aR,4R,6S,6aS)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pentan-3-yl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,2]oxazole-6-carboxylate
• 4H-Cyclopent[d]isoxazole-6-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-, methyl ester, (3aR,4R,6S,6aS)-
• methyl (3aS,4S,6R,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate
• 1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester
• (1S-4R)-4-[[(1
• (3aR,4R,6S,6aS)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cy
• (1S,4R)-4-[[(1,1-diMethylethoxy)carbonyl]amino]- 2-Cyclopent...
• Peramivir impurities5
• TIANFU-CHEM--(1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester
• (3aR,4R,6S,6aS)-4-[[(1,1-DiMethylethoxy)carbonyl]aMino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylic Acid Methyl Ester
• (3aR,4R,6S,6aS)-Methyl 4-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate
• (3aR,4R,6S)-Methyl-4-((tert-butoxycarbonyl)aMino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate
• Methyl 4-{[(tert-butoxy)carbonyl]aMino}-3-(pentan-3-yl)-3aH,4H,5H,6H,6aH-cyclopenta[d][1,2]oxazole-6-carboxylate
• (1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester
• methyl 2-((1R,4R)-4-((tert-butoxycarbonyl)amino)cyclopent-2-en-1-yl)acetate
• Peramivir Intermediate 2